Nanoviricides (NNVC) Income towards Parent Company (2010 - 2026)
Nanoviricides (NNVC) recorded Income towards Parent Company of -$2.22 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$2.1 million a year earlier.
Powered by 
Analysis
Nanoviricides (NNVC) Income towards Parent Company (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides reported Income towards Parent Company of -$8.22 million.
- Across earlier fiscal years, Income towards Parent Company came in at -$9.47 million in FY2025, -$8.29 million in FY2024, -$8.59 million in FY2023 and -$8.11 million in FY2022.
- Quarterly Income towards Parent Company has ranged from -$3.57 million in fiscal Q4 2023 to -$1.57 million in fiscal Q1 2023 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$1.99 million (Q3 2026), -$2.22 million (Q2 2026) and -$1.79 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Nanoviricides | 32.44 Mn | 20.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.22 Mn |
| Mar 31, 2026 | -1.99 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -1.79 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | -3.13 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Mar 31, 2024 | -1.85 Mn |
| Dec 31, 2023 | -2.11 Mn |
| Sep 30, 2023 | -1.97 Mn |
| Jun 30, 2023 | -3.57 Mn |
| Mar 31, 2023 | -1.70 Mn |
| Dec 31, 2022 | -1.75 Mn |
| Sep 30, 2022 | -1.57 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Mar 31, 2022 | -1.79 Mn |
| Dec 31, 2021 | -1.92 Mn |
| Sep 30, 2021 | -2.61 Mn |
API Access
Nanoviricides Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();